← Back to Search
Transient Elastography For The Diagnosis Of Liver Fibrosis: A Systematic Review Of Economic Evaluations
S. Katwyk, D. Coyle, C. Cooper, K. Pussegoda, Chris Cameron, B. Skidmore, S. Brener, D. Moher, K. Thavorn
Published 2017 · Medicine
Download PDFAnalyze on Scholarcy
Liver biopsy remains the gold standard for the diagnosis of liver fibrosis, but its use as a diagnostic tool is limited by its invasive nature and high cost.
This paper references
Biomedical research: increasing value, reducing waste
Published Online (2014)
Cost‐effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation
C. Crossan (2016)
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
R. Myers (2012)
Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
C. Crossan (2015)
An evaluation of the potential cost‐effectiveness of non‐invasive testing strategies in the diagnosis of significant liver fibrosis
J. Carlson (2009)
Ultrasound Elastography in the Assessment of Liver Fibrosis
Q. Lu (2016)
Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications
L. Benvegnù (2004)
An appraisal of the histopathological assessment of liver fibrosis
R. A. Standish (2006)
Methods for the economic evaluation of health care programmes, 3rd ed
G. Adamiak (2006)
Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence
A. Culyer (2007)
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
A. Laupacis (1992)
Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.
G. Sebastiani (2014)
Health Technology Assessment of Transient Elastography in Liver Disease
R Steadman (2012)
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.
S. Ramsey (2005)
Methods for the economic evaluation of health care programmes
S. Wilson (1987)
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.
L. Sandrin (2003)
Willingness to Pay for a Quality-adjusted Life Year
R. Hirth (2000)
Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration
J. Higgins (2013)
Liver Disease in Canada: a Crisis in the Making
Ultrasound Elastography for Fibrosis Surveillance Is Cost Effective in Patients with Chronic Hepatitis C Virus in the UK
C. Canavan (2013)
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
G. D'Amico (2006)
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C
E. Tsochatzis (2014)
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
A. Regev (2002)
Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration
Jp Higgins (2011)
Health Technology Assessment of Transient Elastography in Liver Disease. Calgary, AB: University of Calgary Health Technology Assessment Unit
R Steadman (2012)
Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
M. Stevenson (2012)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
D. Husereau (2013)
PPPs and exchange rates
OECD. StatExtracts (2016)
Reduced mortality rates following elective percutaneous liver biopsies.
J. West (2010)
Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis.
J. Murtagh (2006)
A health technology assessment of transient elastography in adult liver disease.
R. Steadman (2013)
This paper is referenced by
The Use of Transient Elastography Technology in the Bariatric Patient: a Review of the Literature
Max M. Puthenpura (2020)
Position statement on the diagnosis and management of non-alcoholic fatty liver disease.
Khalid Alswat (2019)
Validation of a New Point Shear-Wave Elastography Method for Noninvasive Assessment of Liver Fibrosis: A Prospective Multicenter Study
I. Joo (2019)
Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
Stephanie Wong (2017)
Red cell distribution width to platelet ratio for liver fibrosis: a systematic review and meta-analysis of diagnostic accuracy
Gerasimos P. Milas (2019)
Finite element analysis of shear wave velocity influenced by force in muscle
Qian‐yi Ji (2018)
Evaluation and Staging of Liver Fibrosis-Core Concepts
Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B
W. Yue (2019)
Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses
Rodolfo Castro (2018)
Clinical Aspects of Alcoholic Liver Disease
Mads Israelsen (2019)
Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches
A. Borrelli (2018)
Liver Stiffness Reference Values for Healthy Cuban Adults
Ángela Elvírez-Gutiérrez (2018)
Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil
H. Perazzo (2017)
The Human Gut-Liver-Axis in Health and Disease
Aleksander Krag (2019)
Effectiveness of direct‐acting agents for hepatitis C and liver stiffness changing after sustained virological response
F. Fernandes (2019)
Ultrasound shear wave elastography and liver biopsy to determine liver fibrosis in adult patients
Mohammad Momen Gharibvand (2020)
Noninvasive Biomarkers for the Diagnosis of Liver Fibrosis and Cirrhosis
D. Rosique-Oramas (2019)
Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota.
M. Doulberis (2017)